Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40014564
Localisation
Switzerland
Europe
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
04/04/2024
Statut
Classification
1.5°C
Année cible
2030
Lonza commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2021 base year*. Lonza also commits that 79% of its suppliers by emissions covering purchased goods and services, capital goods and upstream transportation and distribution, will have science-based targets by 2028. *The target boundary includes biogenic land-related emissions and removals from bioenergy feedstocks.
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
CH0013841017
LEI
549300EFW4H2TCZ71055
Source : Science Based Targets initiative | Données publiques